Federal Court Rejects Motion To Dismiss Case In Genomics Patent Infringement Suit
Parse Biosciences’ motion to dismiss a patent infringement case has been rejected by a US District Court.
You may also be interested in...
During Q1, biopharmas brought in an aggregate $17.9bn in financing and device company fundraising totaled $2.2bn; while in vitro diagnostic firms and research tools players raised $1.5bn.
New FDA Documents On Weight-Loss Devices, Software And International Harmonization As End Of Fiscal Year Nears
With the end of fiscal 2023 just over a week away, the US Food and Drug Administration has been publishing promised guidance documents, action plans and white papers. Medtech Insight’s round-up of four device-specific documents is below.
The DHCoE’s new page provides a one-stop-shop for frequently asked digital health policy questions.